Rankings
▼
Calendar
CMMB FY 2023 Earnings — Chemomab Therapeutics Ltd. Revenue & Financial Results | Market Cap Arena
CMMB
Chemomab Therapeutics Ltd.
$12M
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$66,827
Operating Income
-$25M
Net Income
-$24M
EPS (Diluted)
$-8.22
Cash Flow
Operating Cash Flow
-$24M
Free Cash Flow
-$24M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$22M
Total Liabilities
$5M
Stockholders' Equity
$17M
Cash & Equivalents
$9M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$66,827
-$57,773
-15.7%
Operating Income
-$25M
-$29M
+10.8%
Net Income
-$24M
-$28M
+12.4%
← Q4 2022
All Quarters
Q1 2023 →